Crossmark

Integrated transcriptomic and metabolomic analyses reveal targeting hexokinase 2 disrupts glycolysis and nucleotide metabolism to inhibit NSCLC growth

Crossref DOI link: https://doi.org/10.1186/s12957-026-04334-2

Published Online: 2026-05-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Juan

Deng, Rudan

Pan, Linyun

Zhao, Qingqing

Wang, Yan

Wang, Qun

Liu, Yong

Yu, Yang
Funding

Funding for this research was provided by:

Medical Science and Technology Innovation Project of Xuzhou Health and Wellness Committee (XWKYHT20230050)

Xuzhou Pengcheng Talents Medical Young Reserve Talents Project (XWRCHT20220016)
License Information

Text and Data Mining valid from 2026-05-14

Version of Record valid from 2026-05-14
More Information

Article History

Received: 11 August 2025

Accepted: 31 March 2026

First Online: 14 May 2026

Declarations

:

: Not applicable.

: The authors declare no competing interests.

: Not applicable.

Document is current

Any future updates will be listed below